These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23060790)

  • 1. Heme and HO-1 Inhibition of HCV, HBV, and HIV.
    Schmidt WN; Mathahs MM; Zhu Z
    Front Pharmacol; 2012; 3():129. PubMed ID: 23060790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.
    Nio Y; Sasai M; Akahori Y; Okamura H; Hasegawa H; Oshima M; Watashi K; Wakita T; Ryo A; Tanaka Y; Hijikata M
    Antiviral Res; 2019 Sep; 169():104537. PubMed ID: 31207277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?
    Zhu Z; Wilson AT; Luxon BA; Brown KE; Mathahs MM; Bandyopadhyay S; McCaffrey AP; Schmidt WN
    Hepatology; 2010 Dec; 52(6):1897-905. PubMed ID: 21105106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme Oxygenase-1 suppresses duck Tembusu virus replication in vitro.
    Wang Y; Yuyin D; Fengyang C; Xukang Z; Jianliang L
    Vet Microbiol; 2020 Dec; 251():108885. PubMed ID: 33157356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.
    Lehmann E; El-Tantawy WH; Ocker M; Bartenschlager R; Lohmann V; Hashemolhosseini S; Tiegs G; Sass G
    Hepatology; 2010 Feb; 51(2):398-404. PubMed ID: 20044809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
    Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
    Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
    Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
    Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus.
    El Kalamouni C; Frumence E; Bos S; Turpin J; Nativel B; Harrabi W; Wilkinson DA; Meilhac O; Gadea G; Desprès P; Krejbich-Trotot P; Viranaïcken W
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30577437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Antiviral Immunity by Heme Oxygenase-1.
    Espinoza JA; González PA; Kalergis AM
    Am J Pathol; 2017 Mar; 187(3):487-493. PubMed ID: 28082120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.
    Boeijen LL; Hou J; de Groen RA; Verbon A; Boonstra A
    J Virol; 2019 May; 93(9):. PubMed ID: 30185599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.
    Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL
    J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-24-3p promotes porcine reproductive and respiratory syndrome virus replication through suppression of heme oxygenase-1 expression.
    Xiao S; Wang X; Ni H; Li N; Zhang A; Liu H; Pu F; Xu L; Gao J; Zhao Q; Mu Y; Wang C; Sun Y; Du T; Xu X; Zhang G; Hiscox JA; Goodfellow IG; Zhou EM
    J Virol; 2015 Apr; 89(8):4494-503. PubMed ID: 25653454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
    Zhu Z; Wilson AT; Mathahs MM; Wen F; Brown KE; Luxon BA; Schmidt WN
    Hepatology; 2008 Nov; 48(5):1430-9. PubMed ID: 18972446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Induction of Heme Oxygenase-1 Impairs Nuclear Accumulation of Herpes Simplex Virus Capsids upon Infection.
    Ibáñez FJ; Farías MA; Retamal-Díaz A; Espinoza JA; Kalergis AM; González PA
    Front Microbiol; 2017; 8():2108. PubMed ID: 29163402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
    Pereson MJ; Martínez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
    [No Abstract]   [Full Text] [Related]  

  • 18. Heme Oxygenase-1 inhibits spring viremia of carp virus replication through carbon monoxide mediated cyclic GMP/Protein kinase G signaling pathway.
    Li C; Li L; Jin L; Yuan J
    Fish Shellfish Immunol; 2018 Aug; 79():65-72. PubMed ID: 29753142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
    Susser S; Flinders M; Reesink HW; Zeuzem S; Lawyer G; Ghys A; Van Eygen V; Witek J; De Meyer S; Sarrazin C
    Antimicrob Agents Chemother; 2015 May; 59(5):2746-55. PubMed ID: 25712364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.